Add BrightSurf on Google Email

Social participation promotes optimal aging in older adults, research shows

A new study followed over 7,000 middle-aged and older Canadians for three years, finding that social participation was associated with successful aging. Those who engaged in volunteer work and recreational activities were more likely to maintain excellent health and less likely to develop physical or mental problems.

SourceUniversity of Toronto·JournalInternational Journal of Environmental Research and Public Health·TypeSurvey·DateJun 7, 2023

New research finds dramatic increase in illegal ketamine seized by authorities, sparking concern about potential dangers of rising recreational use

A significant increase in illicit ketamine seizures in the US has raised concerns about the risks of non-medical and recreational use, as well as the presence of fentanyl. The study found a 349% rise in seizures from 2017 to 2022, with the highest numbers reported in Tennessee, Florida, and California.

SourceNYU Langone Health / NYU Grossman School of Medicine·JournalJAMA Psychiatry·TypeObservational study·DateMay 24, 2023

Physical activity linked to higher pain tolerance

A new analysis of over 10,000 adults reveals that physically active individuals have higher pain tolerance than sedentary ones. The study suggests that boosting physical activity could be a potential strategy for easing chronic pain.

SourcePLOS·JournalPLOS ONE·TypeSurvey·DateMay 24, 2023

Ready, set, go: New study shows how marathon running affects different foot muscles

A new study found that marathon running causes significant damage to extrinsic foot muscles, while intrinsic muscles are less affected. The research suggests that marathon runners can take steps to prevent injuries by prioritizing recovery and muscle fatigue management.

SourceShibaura Institute of Technology·JournalScandinavian Journal of Medicine and Science in Sports·TypeObservational study·DateMay 23, 2023

Brain signatures for chronic pain identified in a small group of individuals

Researchers have recorded pain-related data from inside the brains of individuals with chronic pain disorders, identifying an area associated with chronic pain and objective biomarkers. The findings, published in Nature Neuroscience, represent a step towards developing novel methods for tracking and treating chronic pain.

BU researchers identify brain marker indicating future suicide risk

Researchers have identified a brain marker that may indicate future suicide risk, suggesting potential new treatments and prevention strategies. The study found differences in brain connections among veterans with a history of suicide attempts compared to those without, which could help identify individuals at risk.

SourceBoston University·JournalJournal of Affective Disorders·TypeImaging analysis·DateMay 17, 2023

Lack of belief in body’s ability to function through pain linked to daily pre-surgery prescribed opioid use among candidates for elective spine surgery

A new Johns Hopkins Medicine study found that patients with low pain self-efficacy are more likely to use daily prescribed opioids before surgery. Surgeons can use pain self-efficacy scores to identify high-risk patients and provide education and counseling to improve post-surgery outcomes.

SourceJohns Hopkins Medicine·JournalThe Spine Journal·DateMay 9, 2023

Most antidepressants prescribed for chronic pain lack reliable evidence of efficacy or safety, scientists warn

A Cochrane review found that most antidepressants used to manage chronic pain lack sufficient evidence of their effectiveness, with only duloxetine showing reliable pain relief. The review also revealed that harms from many commonly recommended drugs have not been well studied, posing a global public health concern.

SourceUniversity of Southampton·JournalCochrane Database of Systematic Reviews·TypeMeta-analysis·DateMay 9, 2023

Neuropathic pain: The underlying mechanism and a potential therapeutic target are revealed in mice

Researchers uncover a pathophysiological mechanism that initiates and sustains neuropathic pain in mice, identifying Tiam1 as a potential therapeutic target. Targeting spinal Tiam1 with antisense oligonucleotides alleviates neuropathic pain hypersensitivity, offering promise for treating chronic pain.

SourceUniversity of Alabama at Birmingham·JournalNeuron·TypeExperimental study·DateMay 4, 2023

Stinging tree injects promise of pain relief

Researchers at University of Queensland have identified a novel pain pathway triggered by the Gympie-Gympie tree's toxins, which could lead to non-opioid pain relief. The gympietide toxin interacts with nerves after injection through fine needle-like hairs on the leaves and requires a partner protein called TMEM233 to function.

SourceUniversity of Queensland·JournalNature Communications·TypeExperimental study·DateMay 3, 2023

Pain out of control

A study by Ruhr-University Bochum's Clinic for Psychosomatic Medicine and Psychotherapy found altered brain activity in patients with fibromyalgia, which may contribute to the disorder's characteristic inability to control pain. The research provides new insights into the neural mechanisms underlying chronic pain in fibromyalgia patients.

SourceRuhr-University Bochum·JournalNeuroImage Clinical·TypeExperimental study·DateApr 5, 2023

Dedicated protocol of hyperbaric oxygen therapy is more effective than the drug treatment available today for fibromyalgia caused by head injury

Researchers at Tel Aviv University found that dedicated hyperbaric oxygen therapy is more effective in reducing pain and healing patients with fibromyalgia caused by traumatic brain injury. The treatment resulted in significant improvements in 2 out of 5 patients, including improved pain threshold tests and quality of life indicators.

SourceTel-Aviv University·JournalPLOS ONE·DateMar 22, 2023

Debunking pain myths could help teens recover faster

A world-first study from the University of South Australia is providing valuable insights into how young people understand chronic pain, potentially helping thousands of sufferers to better manage their symptoms and long-term wellbeing. Researchers found that young people tend to make sense of chronic pain by explaining it as a softwar...

SourceUniversity of South Australia·JournalEuropean Journal of Pain·TypeCase study·DateMar 15, 2023

Review finds fledgling chronic back pain therapy needs more rigorous study

A systematic review of Cognitive Functional Therapy found it to be no better than traditional therapies in reducing pain and disability in people with chronic low back pain. The researchers call for future trials featuring blinded participants and larger sample sizes to improve current evidence.

SourceUniversity of New South Wales·JournalJournal of Orthopaedic and Sports Physical Therapy·TypeSystematic review·DateMar 1, 2023

Overweight and obesity prevalent and poorly managed among adults with type 1 diabetes

A recent study found that adults with type 1 diabetes are at a high risk of being overweight or obese, but only half receive lifestyle recommendations to manage their weight. The study also highlighted the importance of individualized patient education in improving weight management for these patients.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeData/statistical analysis·DateFeb 13, 2023

Medical cannabis for chronic pain may help patients on long-term opioid treatment reduce dosages

A study found that receiving medical cannabis for thirty days or more can lead to a significant reduction in prescription opioid dosages among patients on long-term opioid therapy. Patients who were on higher baseline dosages of prescription opioids experienced larger reductions in opioid dosages.

People with arthritis 20% less likely to be in work

A new study published by the University of Leeds reveals that people with arthritis are 20% less likely to be in work compared to their peers without the condition. The most striking finding is that non-university educated women aged 60-plus are at least 37% less likely to be in work if they have arthritis.

SourceUniversity of Leeds·JournalSocial Science & Medicine Part C Medical Economics·DateJan 30, 2023

Chronic pain-induced depression: Underlying mechanism revealed in mice, showing how ketamine acts as antidepressant in chronic pain

Researchers have uncovered the underlying mechanism driving depressive systems in chronic pain, identifying a potential therapeutic target for treatment. Tiam1 protein modulates neural connections, leading to hypersensitivity and depression; ketamine blocks this effect, alleviating symptoms.

SourceUniversity of Alabama at Birmingham·JournalJournal of Clinical Investigation·TypeExperimental study·DateJan 30, 2023

Chronic pain management program delivered by ‘coaches’ improves outcomes

A new study from Flinders University found that a telehealth program delivering individualized coaching improves self-management and reduces suffering for people with chronic pain. The program, called Rethinking Pain, provides access to care and support for those living in rural areas who face long wait times for specialist care.

SourceFlinders University·JournalPain and Therapy·TypeObservational study·DateJan 15, 2023

Use of cannabis, other pain treatments among adults with chronic pain in states with medical cannabis programs

A survey study found that 3 in 10 adults with chronic pain in states with medical cannabis laws used cannabis to manage their pain, often substituting it for other pain medications. The study highlights the importance of researching the effectiveness and potential adverse consequences of cannabis for chronic pain management.

SourceJAMA Network·JournalJAMA Network Open·DateJan 6, 2023

Does persistent pain impact older adults’ physical function, cognition, and well-being?

Persistent pain was common among US adults aged 65+, with declines in physical function (64% persistent pain, 59% intermittent) and well-being (48% persistent pain, 45% intermittent). Cognitive decline was not significantly affected. The study highlights the importance of access to effective treatment for persistent pain in older adults.

SourceWiley·JournalJournal of the American Geriatrics Society·DateDec 7, 2022

1 in 8 older adults experienced depression for the first time during the COVID-19 pandemic

A large-scale study of 20,000 older adults found that nearly half who had experienced depression before reported being depressed again, highlighting the pandemic's devastating impact on mental health. Factors associated with depression included low income, chronic pain, and family conflict.

SourceUniversity of Toronto·JournalInternational Journal of Environmental Research and Public Health·TypeData/statistical analysis·DateNov 24, 2022

High-fat diet can provoke pain sensitivity without obesity, diabetes

A new study in mice suggests that a short-term high-fat diet can induce hyperalgesic priming and allodynia, even in the absence of injury or preexisting conditions like obesity or diabetes. Researchers found that palmitic acid, a type of saturated fatty acid, binds to nerve cells, causing inflammation and mimicking injury to neurons.

SourceUniversity of Texas at Dallas·JournalScientific Reports·TypeExperimental study·DateNov 14, 2022

Dr. Nathan Hogaboom of Kessler Foundation named winner of the Ernest Bors, MD Award for Scientific Development by the Journal of Spinal Cord Medicine

Dr. Nathan Hogaboom has won the prestigious Ernest Bors, MD Award for Scientific Development for his pioneering work on regenerative rehabilitation research in spinal cord injury. His award-winning study applied novel principles to treat debilitating shoulder pain in wheelchair users with spinal cord injury.

Old drugs hint at new ways to beat chronic pain

A newly identified link between chronic pain and lung cancer in mice suggests that old drugs such as clonidine, capsaicin, and fluphenazine may offer new treatments for chronic pain. The study found that blocking the BH4 pathway reduced pain sensitivity and decreased tumor growth in mouse models of KRAS-driven lung cancer.

SourceIMBA- Institute of Molecular Biotechnology of the Austrian Academy of Sciences·JournalScience Translational Medicine·TypeExperimental study·DateAug 31, 2022